BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18472315)

  • 1. Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices.
    Lai J; Wang J; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):1-12. PubMed ID: 18472315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the intracellular metabolism of antiretroviral nucleosides and nucleotides using liquid chromatography-tandem mass spectrometry and method improvement by using ultra performance liquid chromatography.
    Coulier L; Gerritsen H; van Kampen JJ; Reedijk ML; Luider TM; Osterhaus AD; Gruters RA; Brüll L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2772-82. PubMed ID: 21862423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an assay method for the detection and quantification of protease and non-nucleoside reverse transcriptase inhibitors in plasma and in peripherical blood mononuclear cells by liquid chromatography coupled with ultraviolet or tandem mass spectrometry detection.
    Pèlerin H; Compain S; Duval X; Gimenez F; Bénech H; Mabondzo A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):47-57. PubMed ID: 15797520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
    Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.
    ter Heine R; Davids M; Rosing H; van Gorp EC; Mulder JW; van der Heide YT; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):575-80. PubMed ID: 19168402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients.
    Rivero A; Lozano JM; González R; García-Jurado G; Camacho A; Torres-Cisneros J; Peña J
    Hum Immunol; 2007 Apr; 68(4):303-6. PubMed ID: 17400067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.
    Anderson PL; Kakuda TN; Lichtenstein KA
    Clin Infect Dis; 2004 Mar; 38(5):743-53. PubMed ID: 14986261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.
    Jung BH; Rezk NL; Bridges AS; Corbett AH; Kashuba AD
    Biomed Chromatogr; 2007 Oct; 21(10):1095-104. PubMed ID: 17582235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for liquid chromatography/tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells.
    Becher F; Pruvost A; Gale J; Couerbe P; Goujard C; Boutet V; Ezan E; Grassi J; Benech H
    J Mass Spectrom; 2003 Aug; 38(8):879-90. PubMed ID: 12938109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent analysis of nucleoside reverse transcriptase inhibitors in a pool of endogenous nucleosides by short-end injection-capillary electrochromatography on a beta-cyclodextrin-bonded stationary phase.
    Mesplet N; Morin P; Agrofoglio LA
    Electrophoresis; 2002 May; 23(9):1263-71. PubMed ID: 12007125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
    Fabbiani M; Di Giambenedetto S; Bracciale L; Bacarelli A; Ragazzoni E; Cauda R; Navarra P; De Luca A
    J Antimicrob Chemother; 2009 Jul; 64(1):109-17. PubMed ID: 19398461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular pharmacokinetics of antiretroviral agents.
    Owen A; Khoo SH
    J HIV Ther; 2004 Nov; 9(4):97-101. PubMed ID: 15731742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors.
    Weiss J; Weis N; Ketabi-Kiyanvash N; Storch CH; Haefeli WE
    Eur J Pharmacol; 2008 Jan; 579(1-3):104-9. PubMed ID: 18037401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, simultaneous determination of lopinavir and ritonavir in human plasma by stacking protein precipitations and salting-out assisted liquid/liquid extraction, and ultrafast LC-MS/MS.
    Myasein F; Kim E; Zhang J; Wu H; El-Shourbagy TA
    Anal Chim Acta; 2009 Sep; 651(1):112-6. PubMed ID: 19733744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.
    Kuklenyik Z; Martin A; Pau CP; Holder A; Youngpairoj AS; Zheng Q; Cong ME; Garcia-Lerma JG; Heneine W; Pirkle JL; Barr JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3659-66. PubMed ID: 19783232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/tandem mass spectrometry.
    Lopez LL; Yu X; Cui D; Davis MR
    Rapid Commun Mass Spectrom; 1998; 12(22):1756-60. PubMed ID: 9853385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of macrolide antibiotics, using liquid chromatography-mass spectrometry, in food, biological and environmental matrices.
    Wang J
    Mass Spectrom Rev; 2009; 28(1):50-92. PubMed ID: 18785191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.